Applications of mesoporous materials as excipients for innovative drug delivery and formulation

Current Pharmaceutical Design

Volumn 19, Issue 35, 2013, Pages 6270-6289

  Shen, Shou Cang ^a   Ng, Wai Kiong ^a   Chia, Leonard Sze Onn ^a   Dong, Yuan Cai ^a   Tan, Reginald Beng Hee ^a,b  

^a INSTITUTE OF CHEMICAL AND ENGINEERING SCIENCES   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Drug delivery; Formulation; Mesoporous materials; Multifunctional drug carrier; On demand drug delivery; Poorly soluble drugs

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CAPTOPRIL; CARBAMAZEPINE; CINNARIZINE; CIPROFLOXACIN; CURCUMIN; DANAZOL; DIAZEPAM; DOXORUBICIN; DRUG CARRIER; EXCIPIENT; FAMOTIDINE; FENOFIBRATE; FLUOROURACIL; GENTAMICIN; GENTAMICIN BONE CEMENT; GRISEOFULVIN; HEPARIN; IBUPROFEN; INDOMETACIN; ITRACONAZOLE; KETOCONAZOLE; MESOPOROUS MATERIAL; METHOTREXATE; NANOPARTICLE; NIFEDIPINE; PHENYLBUTAZONE; QUANTUM DOT; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; POLYMERIZATION; POROSITY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANIMALS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; EXCIPIENTS; HUMANS; NANOPARTICLES; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; POROSITY; SILICON DIOXIDE; SOLUBILITY;

EID: 84887896558     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319350005     Document Type: Article

References (145)

1. Vallet-Regí M, Ramila A, del Real RP, Pariente JP. A new property of MCM-41: Drug delivery system. Chem Mater 2001; 13: 308-11.
2. Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Chem Int Ed 2007; 46: 7548-58.
3. Mazanoab M, Vallet-Regí M. New developments in ordered mesoporous materials for drug delivery. J Mater Chem 2010; 20: 5593-604.
4. Cariono IS, Pasqua L, Testa F, et al. Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Deliv 2007; 14: 491-5.
5. Prokopowicz M, Przyjazny A. Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin. J Microencapsul 2007; 24: 694-713.
6. Nunes CD, Vaz PD, Fernandes AC, Ferreira P, Romäo CC, Calhordo MJ. Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur J Pharm Biopharm 2007; 66: 357-65.
7. Wang S. Ordered mesoporous materials for drug delivery. Micropor Mesopor Mat 2009; 117: 1-9.
8. Pasqua L, Cundari S, Ceresa C, Cavaletti G. Recent development, applications, and perspectives of mesoporous silica particles in medicine and biotechnology. Curr Med Chem 2009; 16: 3054-63.
9. Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliver Rev 2008; 60: 1278-88.
10. Manzano M, Colilla M, Vallet-Regí M. Drug delivery from ordered mesoporous matrices. Expert Opin Drug Del 2009; 6: 1383-400.
11. Lu J, Liong M, Li Z, Zink JI, Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010; 6: 1794-805.
12. Kim T-W, Slowing II, Chung PW, Lin VSY. Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules. ACS Nano 2010; 5: 360-6.
13. Gao Y, Chen Y, Ji X, et al. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shellpore sizes of mesoporous silica nanoparticles. ACS Nano, 2011, 5: 9788-98.
14. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 2010; 6: 1952-67.
15. He Q, Shi J, Chen F, Zhu M, Zhang L. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 2010; 31: 3335-46.
16. Doadrio AL, Sousa EM, Doadrio JC, Pérez Pariente J, Izquierdo-Barba I, Vallet-Regí M. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J Control Release 2004; 97: 125-32.
17. Andersson J, Rosenholm J, Lindén M. Mesoporous silica: An alternative diffusion controlled drug delivery system. In: Ashammakhi N. Ed. Topics in multifunctional biomaterials and devices, e-book, Vol 1, 2008.
18. Izquierdo-Barba I, Sousa E, Doadrio JC, et al. Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15. J Sol-Gel Sci Techn 2009; 50: 421-9.
19. Qu F, Lin H, Wu X, Li X, Qiu S, Zhu G. Bio-templated synthesis of highly ordered macro-mesoporous silica material for sustained drug delivery. Solid State Sci 2010; 12: 851-6.
20. Lopez T, Ortiz E, Alexander-Katz R, Basaldella E, Bokhimi X. Cortisol controlled release by mesoporous silica. Nanomed-Nanotechnol 2009; 5: 170-7.
21. Shen SC, Ng WK, Shi Z, Chia L, Neoh KG, Tan RBH. Mesoporous silica nanoparticle-functionalized poly(methyl methacrylate)-based bone cement for effective antibiotics delivery. J Mater Sci-Mater M 2011; 22: 2283-92.
22. Zhu M, Shi J, He Q, Zhang L, Chen F, Chen Y. An emulsificationsolvent evaporation route to mesoporous bioactive glass microspheres for bisphosphonate drug delivery. J Mater Sci 2012; 47: 2256-63.
23. Bernados A, Aznar E, Coll C, et al. Controlled release of vitamin B2 using mesoporous materials functionalized with amine-bearing gate-like scaffoldings. J Control Release 2008; 131: 181-9.
24. Manano M, Aina V, Areán CO, et al. Studies on MCM-41 mesoporous silica for drug delivery: Effect of particle morphology and amine functionalization. Chem Eng J 2008; 137: 30-7.
25. González B, Colilla M, López de Laorden C, Vallet-Regí M. A novel synthetic strategy for covalently bonding dendrimers to ordered mesoporous silica: potential drug delivery applications. J Mater Chem 2009; 19: 9012-24.
26. Das SK, Kapoor S, Yamada H, Battacharyya AJ. Effects of surface acidity and pore size of mesoporous alumina on degree of loading and controlled release of ibuprofen. Micropor Mesopor Mat 2009; 118: 267-72.
27. Shen SC, Chow PS, Chen F, Tan RBH. Submicron particles of SBA-15 modified with MgO as carriers for controlled drug delivery. Chem Pharm Bull 2007; 55: 985-91.
28. Wu Z, Jiang Y, Kim T, Lee K. Effects of surface coating on he controlled release of vitamin B1 from mesoporous silica tablets. J Control Release 2007; 119: 215-21.
29. Asefa T, Otuonye AN, Wang G, Blair EA, Vathyam R, Denton K. Controlling adsorption and release of drug and small molecules by organic functionalization of mesoporous materials. Adsorption 2009; 15: 287-99.
30. Lee CH, Lo LW, Mou CY, Yang CS. Synthesis and characterization of positive-charge functionalize mesoporous silica nanoparticles for oral drug delivery of an anti-inflammatory drug. Adv Funct Mater 2008; 18: 3283-92.
31. Lin H, Zhu, G, Xing J, Gao, B, Qiu S. Polymer-mesoporous silica materials templated with an oppositely charged surfactant/polymer system for drug delivery. Langmuir 2009; 25: 10159-64.
32. Tang Q, Chen Y, Chen J, et al. Drug delivery from hydrophobicmodified mesoporous silicas: Control via modification level and site-selective modification. J Solid State Chem 2010; 183: 76-83.
33. Gao L, Sun J, Li Y, Zhang L. Bimodal mesoporous silicas functionalized with different level and species of the amino groups for adsorption and controlled release of aspirin. J Nanosci Nanotechno 2011; 11: 6690-7.
34. Parambadath S, Rana VK, Zhao D, Ha CS. N, N0-diureylenepiperazine-bridged periodic mesoporous organosilica for controlled drug delivery. Micropor Mesopor Mater 2011; 141: 94-101.
35. Carino IS, Testa F, Puoci F, Pasqua L, Aiello R. Polymer coated silica-based mesoporous materials for controlled drug release. In: Zeolites and Related Materials: Trends, Targets and Challenges. Proceedings of 4th International FEZA Conference, Paris, France, Sept. 2-6, 2008; pp 373-6.
36. Li K, Zhou Y, Yang JY, Zhu JH, Liu CJ. In vitro biocompatibility evaluation of ePTFE graft with controlled release of heparin from mesoporous material. Appl Surf Sci 2012; 258: 404-7.
37. Zhu Y, Fang Y, Borchardt L, Kaskel S. PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles. Micropor Mesopor Mater 2011; 141: 199-206.
38. Tang J, Slowing II, Huang Y, et al. Poly(lactic acid)-coated mesoporous silica nanosphere for controlled release of venlafaxine. J Colloid Interf Sci 2011; 360: 488-96.
39. Ehlert N, Badar M, Christel A, et al. Mesoporous silica coatings for controlled release of the antibiotic ciprofloxacin from implants. J Mater Chem 2011; 21: 752-60.
40. Restani RB, Correria VG, Bonifácio VDB, Aguiar-Ricardo A. Development of functional mesoporous microparticles for controlled drug delivery. J Supercrit Fluid 2010; 55: 333-9.
41. Hong CY, Li X, Pan CY. Fabrication of smart nanocontainers with a mesoporous core and a pH-responsive shell for controlled uptake and release. J Mater Chem 2009; 19: 5155-60.
42. Cheng SH, Liao WN, Chen LM, Lee CH. pH-controllable release using functionalized mesoporous silica nanoparticles as an oral drug delivery system. J Mater Chem 2011; 21: 7130-7.
43. Jin D, Park KW, Lee JH, et al. The selective immobilization of curcumin onto the internal surface of mesoporous hollow silica particles by covalent bonding and its controlled release. J Mater Chem 2011; 21: 3641-5.
44. Liu J, Du X. pH-and competitor-driven nanovalves of cucurbit[7]uril pseudorotaxanes based on mesoporous silica supports for controlled release. J Mater Chem 2010; 20: 3642-9.
45. He Q, Gao Y, Zhang L, et al. One-pot self-assembly of mesoporous silica nanoparticle-based pH-responsive anti-cancer nano drug delivery system. J Mater Chem 2011; 21: 15190-2.
46. Rim HP, Min KH, Lee HJ, Jeong SY, Lee SC. pH-tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs. Angew Chem Int Edit 2011; 50: 8853-7.
47. Muhammad F, Guo M, Qi W, et al. pH-triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. J Am Chem Soc 2011; 133: 8778-81.
48. Lee CH, Cheng SH, Huang IP, et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Chem Int Edit 2010; 49: 8214-9.
49. Zheng H, Wang Y, Che S. Coordination bonding-based mesoporous silica for pH-responsive anticancer drug doxorubicin delivery. J Phys Chem C 2011; 115: 16803-13.
50. Yuan L, Tang Q, Yang D, Zhang JZ, Zhang F, Hu J. Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery. J Phys Chem C 2011; 115: 9926-32.
51. Tang H, Guo J, Sun Y, Chang B, Ren Q, Yang W. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Int J Pharm 2011; 421: 388-96.
52. Liu R, Liao P, Liu J, Feng P. Responsive polymer-coated mesoporous silica as a pH-sensitive nanocarrier for controlled release. Langmuir 2011; 27: 3095-9.
53. Zhu Y, Shi J. A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug. Micropor Mesopor Mater 2007; 103: 243-9.
54. Yang YJ, Tao X, Hou Q, Ma Y, Chen XL, Chen JF. Mesoporous silica nanotubes coated with multilayered polyelectrolytes for pHcontrolled drug release. Acta Biomater 2010; 6: 3092-3100.
55. Mei X, Chen D, Li N, et al. Hollow mesoporous silica nanoparticles conjugated with pH-sensitive amphiphilic diblock polymer for controlled drug release. Micropor Mesopor Mater 2012; 152: 16-24.
56. Sun JT, Hong CY, Pan CY. Fabrication of PDEAEMA-coated mesoporous silica nanoparticles and pH-responsive controlled release. J Phys Chem C 2010; 114: 12481-6.
57. He Q, Gao Y, Zhang L, et al. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. Biomaterials 2011; 32: 7711-20.
58. Xu W, Gao Q, Xu Y, Wu D, Sun Y. pH-controlled drug release from mesoporous silica tablets coated with hydroxypropyl methylcellulose phthalate. Mater Res Bull 2009; 44: 606-12.
59. Xia W, Chang J, Lin J, Zhu J. The pH-controlled dual-drug release from mesoporous bioactive glass/polypeptide graft copolymer nanomicelle composites. Eur J Pharm Biopharm 2008; 69: 546-52.
60. de Sousa A, Maria DA, de Sousa RG, de Sousa EMB. Synthesis and characterization of mesoporous silica/poly(Nisopropylacrylamide) functional hybrid useful for drug delivery. J Mater Sci 2010; 45: 1478-86.
61. Tian BS, Yang C. Thermo-sensitive poly(N-isopropylacrylamide)/mesoporous silica nanocomposites as controlled delivery carriers: Loading and release behaviors for drug ibuprofen. J Nanosci Nanotechno 2011; 11: 1871-9.
62. Zhu S, Chen C, Chen Z, et al. Thermo-responsive polymerfunctionalized mesoporous carbon for controlled drug release. Mater Chem Phys 2011; 126: 357-63.
63. Schlossbauer A, Warncke S, Gramlich PME, et al. A programmable DNA-based molecular valve for colloidal mesoporous silica. Angew Chem Int Edit 2010; 49: 4734-7.
64. Aznar E, Mondragón L, Ros-Lis JV, et al. Finely tuned temperature-controlled cargo release using paraffin-capped mesoporous silica nanoparticles. Angew Chem Int Edit 2011; 50: 11172-5.
65. Thornton PD, Heise A. Highly specific dual enzyme-mediated payload release from peptide-coated silica particles. J Am Chem Soc 2010; 132: 2024-8.
66. Zhao Y, Trewyn BG, Slowing II, Lin VSY. Mesoporous silica nanoparticle-based double drug delivery system for glucoseresponsive controlled release of insulin and cyclic AMP. J Am Chem Soc 2009; 131: 8398-400.
67. Mortera R, Vivero-Escoto J, Slowing II, Garrone E, Onida B, Lin VSY. Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system. Chem Commun 2009; 45: 3219-21.
68. Schlossbauer A, Kecht J, Bein T. Biotin-avidin as a proteaseresponsive cap system for controlled guest release from colloidal mesoporous silica. Angew Chem Int Edit 2009; 48: 3092-5.
69. Bernados A, Aznar E, Marcos MD, et al. Enzyme-responsive controlled release using mesoporous silica supports capped with lactose. Angew Chem Int Edit 2009; 48: 5884-87.
70. Bernados A, Mondragón L, Aznar E, et al. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides. " ACS Nano 2010; 4: 6353-68.
71. Chen C, Geng J, Pu F, Yang X, Ren J, Qu X. Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: Dual stimuliresponsive vehicles for intracellular drug delivery. Angew Chem Int Edit 2011; 50: 882-6.
72. Coll C, Mondragón L, Martínez-Máňez R, et al. Enzyme-mediated controlled release systems by anchoring peptide sequences on mesoporous silica supports. Angew Chem Int Edit 2011; 50: 2138-40.
73. Zhu CL, Lu CH, Song XY, Yang HH, Wang XR. Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate. J Am Chem Soc 2011; 133: 1278-81.
74. Zhao W, Zhang H, He Q, et al. A glucose-responsive controlled release of insulin system based on enzyme multilayers-coated mesoporous silica particles. Chem Commun 2011; 47: 9459-61.
75. Vivero-Escoto JL, Slowing II, Wu CW, Lin VSY. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J Am Chem Soc 2009; 131: 3462-3.
76. Lin HM, Wang WK, Hsiung PA, Shyu SG. Light-sensitive intelligent drug delivery systems of coumarin-modified mesoporous bioactive glass. Acta Biomater 2010; 6: 3256-63.
77. Aznar E, Casasús R, García-Acosta B, et al. Photochemical and chemical two-channel control of functional nanogated hybrid architectures. Adv Mater 2007; 19: 2228-31.
78. Lu J, Choi E, Tamanoi F, Zink JI. Light-activated nanoimpellercontrolled drug release in cancer cells. Small 2008; 4: 421-6.
79. Knéevi N, Trewyn BG, Lin VSY. Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system. Chem Commun 2011; 47: 2817-9.
80. Ibsen S, Benchimol M, Simberg D, Schutt C, Steiner J, Esner S. A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload. J Control Release 2011; 155: 358-66.
81. Du L, Jin Y, Zhou W, Zhao J. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D, Llactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets. Ultrasound Med Biol 2011; 37: 1252-8.
82. Depan D, Saikia L, Singh RP. Ultrasound-triggered release of ibuprofen from a chitosan-mesoporous silica composite-a novel approach for controlled drug release. Macromol Symp 2010; 287: 80-8.
83. Ma, S, Wang Y, Zhu Y. A simple room temperature synthesis of mesoporous silica nanoparticles for drug storage and pressure pulsed delivery. J Porous Mater 2011; 18: 233-9.
84. 4-capped mesoporous silica nanoparticles for intracellular controlled release and MR imaging. J Mater Chem 2011; 21: 2535-43.
85. Cho YL, Jaworski J, Seo ML, Lee SJ, Jung JH. Controlled release using mesoporous silica nanoparticles functionalized with 18-crown-6 derivative J Mater Chem 2011; 21: 7882-5.
86. He Q, Shi J, Chen F, Zhu M, Zhang L. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 2010; 31: 3335-46.
87. Rosenholm JM, Peuhu E, Bate-Eya LT, Eriksson JE, Sahlgren C, Lindén M. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small 2010; 6: 1234-41.
88. 2 hollow mesoporous spheres as carriers for drug delivery. Small 2010; 6: 471-8.
89. Rosenholm JM, Sahlgren C, Lindén M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles-opportunities & challenges. Nanoscale 2010; 2: 1870-83.
90. Ferris DP, Lu J, Gothard C, et al. Synthesis of biomoleculemodified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells. Small 2011; 7: 1816-26.
91. Mamaeval V, Rosenholm JM, Bate-Eya LT, et al. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of notch signaling in cancer. Mol Ther 2011; 19: 1538-46.
92. Luo Z, Cai K, Hu Y, et al. Mesoporous silica nanoparticles endcapped with collagen: Redox-responsive nanoreservoirs for targeted drug delivery. Angew Chem Int Edit 2011; 50: 640-3.
93. 2 hollow mesoporous spheres for targeted anticancer drug delivery. J Phys Chem C 2010; 114: 16382-8.
94. Wang LS, Wu LC, Lu SY, et al. Biofunctionalized phospholipidcapped mesoporous silica nanoshuttles for targeted drug delivery: Improved water suspensibility and decreased nonspecific protein binding. ACS Nano 2010; 4: 4371-9.
95. Wang T, Chai F, Fu Q, et al. Uniform hollow mesoporous silica nanocages for drug delivery in vitro and in vivo for liver cancer therapy. J Mater Chem 2011; 21: 5299-306.
96. Mohapatra S, Rout SR, Maiti S, Maitib TK, Panda AB. Monodisperse mesoporous cobalt ferrite nanoparticles: synthesis and application in targeted delivery of antitumor drugs. J Mater Chem 2011; 21: 9185-93.
97. Arcos D, López-Noriega A, Ruiz-Hernández E, Terasaki O, Vallet-Regí. Ordered mesoporous microspheres for bone grafting and drug delivery. Chem Mater 2009; 21: 1000-9.
98. Sousa A, Souza KC, Sousa EMB. Mesoporous silica/apatite nanocomposite: Special synthesis route to control local drug delivery. Acta Biomater 2008; 4: 671-9.
99. Cauda V, Fiorilli S, Onida B, et al. SBA-15 ordered mesoporous silica inside a bioactive glass-ceramic scaffold for local drug delivery. J Mater Sci: Mater Med 2008; 19: 3303-10.
100. Souza KC, Ardisson JD, Sousa EMB. Study of mesoporous silica/magnetite systems in drug controlled release. J Mater Sci: Mater Med 2009; 20: 507-12.
101. Zhao W, Chen H, Li Y, Li L, Lang M, Shi J. Uniform rattle-type hollow magnetic mesoporous spheres as drug delivery carriers and their sustained-release property. Adv Funct Mater 2008; 18: 2780-8.
102. Guo S, Li D, Zhang L, Li J, Wang E. Monodisperse mesoporous superparamagnetic single-crystal magnetite nanoparticles for drug delivery. Biomaterials 2009; 30: 1881-9.
103. Chen Y, Chen H, Zeng D, et al. Core/shell structured hollow mesoporous nanocapsules: A potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 2010; 4: 6001-13.
104. Huang S, Fan Y, Cheng Z, et al. Magnetic mesoporous silica spheres for drug targeting and controlled release. J Phys Chem C 2009; 113: 1775-84.
105. Chang B, Guo J, Liu C, Qian J, Yang W. Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release. J Mater Chem 2010; 20: 9941-7.
106. Liu C, Guo J, Yang W, Hu J, Wang C, Fu S. Magnetic mesoporous silica microspheres with thermo-sensitive polymer shell for controlled drug release. J Mater Chem 2009; 19: 4764-70.
107. Chang B, Sha X, Guo J, Jiao Y, Wang C, Yang W. Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release. J Mater Chem 2011; 21: 9239-47.
108. Wu H, Liu G, Zhang S, et al. Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands. J Mater Chem 2011; 21: 3037-45.
109. Guo YP, Guo LH, Yao YB, Ning CQ, Guo YJ. Magnetic mesoporous carbonated hydroxyapatite microspheres with hierarchical nanostructure for drug delivery systems. Chem Commun 2011; 47: 12215-7.
110. Wu C, Fan W, Zhu Y, et al. Multifunctional magnetic mesoporous bioactive glass scaffolds with a hierarchical pore structure. Acta Biomater 2011; 7: 3563-72.
111. Yang P, Quan Z, Lu L, Huang S, Lin J. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems. Biomaterials 2008; 29: 692-702.
112. 3+ particles for drug release. J Nanomater 2008; 2008: 312792.
113. Huang CC, Huang W, Yeh CS. Shell-by-shell synthesis of multishelled mesoporous silica nanospheres for optical imaging and drug delivery. Biomaterials 2011; 32: 556-64.
114. 2 nanospheres as carriers for drug delivery. J Phys Chem C 2011; 115: 15801-11.
115. 3: Yb, Er Core/mesoporous silica shell structure. Eur J Inorg Chem 2010; 2010: 5195-9.
116. He Q, Shi J, Cui X, et al. Synthesis of oxygen-deficient luminescent mesoporous silica nanoparticles for synchronous drug delivery and imaging. Chem Commun 2011; 47: 7947-9.
117. Li D, Yu J, Xu R. Mesoporous silica functionalized with an AIE luminogen for drug delivery. Chem Commun 2011; 47: 11077-9.
118. 2 nanocapsules for drug delivery and fluorescence imaging of cancer cells. J Colloid Interf Sci 2011; 358: 109-15.
119. Sauer AM, Schlossbauer A, Ruthardt N, Cauda V, Bein T, Bräuchle C. Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-Cell imaging. Nano Lett 2010; 10: 3684-91.
120. Zhang C, Li C, Huang S, et al. Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery. Biomaterials 2010; 31: 3374-83.
121. Yang P, Yang P, Teng X, Lin J, Huang J. A novel luminescent mesoporous silica/apatite composite for controlled drug release. J Mater Chem 2011; 21: 5505-10.
122. Di W, Ren X, Zhao H, Shirahata N, Sakka Y, Qin W. Singlephased luminescent mesoporous nanoparticles for simultaneous cell imaging and anticancer drug delivery. Biomaterials 2011; 32: 7226-33.
123. Wu KCW, Yamauchi Y, Hong CY, et al. Biocompatible, surface functionalized mesoporous titania nanoparticles for intracellular imaging and anticancer drug delivery. Chem Commun 2011; 47: 5323-4.
124. Kim J, Kim HS, Lee N, et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Edit 2008; 47: 8438-41.
125. Lee JE, Lee N, Kim H, et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc 2010; 132: 552-7.
126. Lee JE, Lee DJ, Lee N, Kim BH, Choi SH, Hyeon T. Multifunctional mesoporous silica nanocomposite nanoparticles for pH controlled drug release and dual modal imaging. J Mater Chem 2011; 21: 16869-72.
127. Chen Y, Chen H, Zhang S, et al. Multifunctional mespporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv Funct Mater 2011; 21: 270-8.
128. Wu H, Zhang S, Zhang J, et al. A hollow-core, magnetic, and mesoporous double-shell nanostructure: in situ decomposition/reduction synthesis, bioimaging, and drug-delivery properties. Adv Funct Mater 2011; 21: 1850-62.
129. Qian KK, Bogner RH. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J Pharm Sci 2012; 101: 444-63.
130. Mellaerts R, Aerts CA, van Humbeeck J, et al. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. Chem Commun 2007; 7: 1375-7.
131. Mellaerts R, Mols R, Jammaer JAG, et al. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur J Pharm Biopharm 2008; 69: 223-30.
132. Mellaerts R, Houthoofd K, Elen K, et al. Aging behavior of pharmaceutical formulations of itraconazole on SBA-15 ordered mesoporous silica carrier material. Micropor Mesopor Mater 2010; 130: 154-61.
133. van Speybroeck M, Barillaro V, Thi TD, et al. Ordered mesoporous silica material SBA-15: A broad-spectrum formulation platform for poorly soluble drugs. J Pharm Sci 2009; 98: 2648-58.
134. van Speybroeck M, Mellaerts R, Thi TD, et al. Preventing release in the acidic environment of the stomach via occlusion in ordered mesoporous silica enhances the absorption of poorly soluble weakly acidic drugs. J Pharm Sci 2011; 100: 4864-76.
135. Wang F, Hui H, Barnes TJ, Barnett C, Prestidge CA. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Mol Pharm 2009; 7: 227-36.
136. van Speybroeck M, Mellaerts R, Mols R, Thi TD, et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. European Journal of Pharmaceutical Sciences 41 (2010) 623-630.
137. Zhang Y, Zhi Z, Jiang T, Zhang J, Wang Z, Wang S. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release 2010; 145: 257-63.
138. Hu Y, Wang J, Zhi Z, Jiang T, Wang S. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J Colloid Interf Sci 2011; 363: 410-7.
139. Hu Y, Zhi Z, Zhao Q, et al. 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Micropor Mesopor Mater 2012; 147: 94-101.
140. Zhao Q, Wang T, Wang J, et al. Fabrication of mesoporous hydroxycarbonate apatite for oral delivery of poorly water-soluble drug carvedilol. J Non-Cryst Solids 2012; 358: 229-35.
141. Limnell T, Santos HA, Mäkilä E, et al. Drug delivery formulations of ordered and nonordered mesoporoussSilica: Comparison of three drug loading methods. J Pharm Sci 2011; 100: 3294-306.
142. Mellaerts R, Jammaer JA, van Speybroeck M, et al. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen. Langmuir 2008; 24: 8651-9.
143. Shen SC, Ng WK, Chia L, Dong YC, Tan RBH. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties. J Pharm Sci 2010; 99: 1997-2007.
144. Shen SC, Ng WK, Chia L, Hu J, Tan RBH. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Int J Pharm 2011; 410: 188-95.
145. van Speybroeck M, Mols R, Mellaerts R, et al. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole. Eur J Pharm Biopharm 2010; 75: 354-65.